Hypothyroidism epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypothyroidism}} | {{Hypothyroidism}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Overview== | |||
==Epidemiology and Demographics== | |||
It affects about 5% of the United Kingdom population over 60 years of age. As of 2006, more than 1% of the United Kingdom population were receiving T<sub>4</sub> ([[Thyroxine]]) replacement therapy for hypothyroidism.<ref name="tjcemjul06">{{cite journal |author=Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L |title=Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials |journal=J. Clin. Endocrinol. Metab. |volume=91 |issue=7 |pages=2592-9 |year=2006 |month=July |pmid=16670166 |doi=10.1210/jc.2006-0448}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 00:55, 19 September 2012
|
Hypothyroidism Main page |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Epidemiology and Demographics
It affects about 5% of the United Kingdom population over 60 years of age. As of 2006, more than 1% of the United Kingdom population were receiving T4 (Thyroxine) replacement therapy for hypothyroidism.[1]
References
- ↑ Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L (2006). "Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials". J. Clin. Endocrinol. Metab. 91 (7): 2592–9. doi:10.1210/jc.2006-0448. PMID 16670166. Unknown parameter
|month=ignored (help)